Nasdaq · Biotech stocks database

ANL — Adlai Nortye Group Ltd.

ANL (Adlai Nortye Group Ltd.) stock: $15.74, $1.01B market cap, $8.1M cash, $1.03B EV, $861.3M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$15.74

Market cap

$1,013.6M

Cash

$8.1M

Enterprise value

$1,031.9M

Balance sheet

Cash	$8.1M
Debt	$26.3M
Net cash	-$18.3M
Enterprise value	$1,031.9M
Basic shares	64.4M shares
Fully diluted shares	54.7M shares
Fully diluted market cap	$861.3M
Cash per share	$0.13

Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.

Price history

Loading ANL daily closes…

Loading price history…

Institutional holders

Fund	Shares	Q/Q change	% of portfolio	Filing
ADAR1 Capital Management	1,017,805	+899,896	0.55%	2026-08-14
Braidwell LP	795,214	+795,214	0.34%	2026-08-14
Ikarian Capital	33,899	no change	0.06%	2026-08-14

Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego